Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Fa

Showing results (421-430 of 458) with videos related to

Pageof 46
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Nipah virus dynamics in bats and implications for spillover to humansJonathan H Epstein, Simon J Anthony, Ariful Islam, et al.
Singapore Medical Journal|April 10, 2025
Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learntJun Yang Tay, Sharavan Sadasiv Mucheli, Bingwen Eugene Fan, et al.
The Lancet. Infectious Diseases|July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprintingHareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Ebiomedicine|April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational studyBarnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
JAMA|March 4, 2020
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeBarnaby Edward Young, Sean Wei Xiang Ong, Shirin Kalimuddin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) SeverityBarnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
Pageof 46

Showing results (421-430 of 458) with videos related to

Sort By:
Pageof 46
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Nipah virus dynamics in bats and implications for spillover to humansJonathan H Epstein, Simon J Anthony, Ariful Islam, et al.
Singapore Medical Journal|April 10, 2025
Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learntJun Yang Tay, Sharavan Sadasiv Mucheli, Bingwen Eugene Fan, et al.
The Lancet. Infectious Diseases|July 4, 2024
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29Kristine A Moore, Angela J Mehr, Julia T Ostrowsky, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprintingHareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Ebiomedicine|April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational studyBarnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
JAMA|March 4, 2020
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeBarnaby Edward Young, Sean Wei Xiang Ong, Shirin Kalimuddin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) SeverityBarnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
Pageof 46